TMVR: Early benefits, late questions

Transcatheter mitral valve replacement (TMVR) appears to have better early survival compared to surgical mitral valve replacement (SMVR). Over the long‐term, TMVR has attenuated survival compared to SMVR and this attributed to advanced age, chronic lung disease, more advanced heart failure and pulmo...

Full description

Saved in:
Bibliographic Details
Published inCatheterization and cardiovascular interventions Vol. 99; no. 5; pp. 1666 - 1667
Main Authors Eng, Marvin H., Fang, H. Kenith
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.04.2022
Subjects
Congestive heart failure
Heart diseases
heart failure
Humans
Lung diseases
Mitral Valve
Mitral Valve Insufficiency
Rheumatic heart disease
surgical mitral valve replacement
Survival
transcatheter mitral valve replacement
Treatment Outcome
valvular heart disease
heart failure
transcatheter mitral valve replacement
valvular heart disease
surgical mitral valve replacement
Online AccessGet full text

Cover

More Information
Summary:Transcatheter mitral valve replacement (TMVR) appears to have better early survival compared to surgical mitral valve replacement (SMVR). Over the long‐term, TMVR has attenuated survival compared to SMVR and this attributed to advanced age, chronic lung disease, more advanced heart failure and pulmonary hypertension. Low rates of mortality for TMVR are likely linked to the iterative improvement in techniques to use transseptal access for implantation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1522-1946
1522-726X
1522-726X
DOI:10.1002/ccd.30208